Details
Stereochemistry | EPIMERIC |
Molecular Formula | C15H18ClNO3 |
Molecular Weight | 295.761 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 3 |
E/Z Centers | 0 |
Charge | 0 |
Stereo Comments | 5-OXAZONE |
SHOW SMILES / InChI
SMILES
C[C@H]1OC2(CCCC[C@H]2OC3=CC(Cl)=CC=C3)NC1=O
InChI
InChIKey=PSHBCUHYCLAGPZ-BAOLWLNASA-N
InChI=1S/C15H18ClNO3/c1-10-14(18)17-15(20-10)8-3-2-7-13(15)19-12-6-4-5-11(16)9-12/h4-6,9-10,13H,2-3,7-8H2,1H3,(H,17,18)/t10-,13-,15?/m1/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/6805026
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6805026
Enilospirone (CERM-3726) is essentially a central stimulant. At low doses (100 mg) it may improve performance and at higher doses it may lead to disturbance of sleep continuity. These effects may not involve DA mechanisms, though changes such as those in REM sleep with chronic ingestion could involve the noradrenergic pathway. The property of the drug, even at low doses, to oppose the deterioration in performance associated with tests of prolonged duration is likely to be due to a mild alerting effect.
CNS Activity
Originator
Sources: Caille EJ, Bassano JL, Lacoste JP, Ponlain PH (1978) Etude de la molecule 3726 CERM au niveau du processus hypnique, de l'activite cerebrale en etat de veille et de la disponibilite au reveil. Psychol Med 10:1823-1837
Curator's Comment: reference retreived from https://www.ncbi.nlm.nih.gov/pubmed/6805026
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6805026
Immediate effects on sleep of 100, 200 and 300 mg enilospirone were studied in six healthy males.
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C28197
Created by
admin on Fri Dec 15 16:30:21 GMT 2023 , Edited by admin on Fri Dec 15 16:30:21 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C034011
Created by
admin on Fri Dec 15 16:30:21 GMT 2023 , Edited by admin on Fri Dec 15 16:30:21 GMT 2023
|
PRIMARY | |||
|
DTXSID001024237
Created by
admin on Fri Dec 15 16:30:21 GMT 2023 , Edited by admin on Fri Dec 15 16:30:21 GMT 2023
|
PRIMARY | |||
|
59798-73-1
Created by
admin on Fri Dec 15 16:30:21 GMT 2023 , Edited by admin on Fri Dec 15 16:30:21 GMT 2023
|
PRIMARY | |||
|
WO31V62797
Created by
admin on Fri Dec 15 16:30:21 GMT 2023 , Edited by admin on Fri Dec 15 16:30:21 GMT 2023
|
PRIMARY | |||
|
10063117
Created by
admin on Fri Dec 15 16:30:21 GMT 2023 , Edited by admin on Fri Dec 15 16:30:21 GMT 2023
|
PRIMARY | |||
|
261-932-3
Created by
admin on Fri Dec 15 16:30:21 GMT 2023 , Edited by admin on Fri Dec 15 16:30:21 GMT 2023
|
PRIMARY | |||
|
CHEMBL2106117
Created by
admin on Fri Dec 15 16:30:21 GMT 2023 , Edited by admin on Fri Dec 15 16:30:21 GMT 2023
|
PRIMARY | |||
|
5648
Created by
admin on Fri Dec 15 16:30:21 GMT 2023 , Edited by admin on Fri Dec 15 16:30:21 GMT 2023
|
PRIMARY | |||
|
SUB06534MIG
Created by
admin on Fri Dec 15 16:30:21 GMT 2023 , Edited by admin on Fri Dec 15 16:30:21 GMT 2023
|
PRIMARY | |||
|
C74166
Created by
admin on Fri Dec 15 16:30:21 GMT 2023 , Edited by admin on Fri Dec 15 16:30:21 GMT 2023
|
PRIMARY | |||
|
100000080231
Created by
admin on Fri Dec 15 16:30:21 GMT 2023 , Edited by admin on Fri Dec 15 16:30:21 GMT 2023
|
PRIMARY | |||
|
Enilospirone
Created by
admin on Fri Dec 15 16:30:21 GMT 2023 , Edited by admin on Fri Dec 15 16:30:21 GMT 2023
|
PRIMARY |
ACTIVE MOIETY